Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Improvement of driver active interventions during automated driving by displaying trajectory pointers-A driving simulator study.

Ono S, Sasaki H, Kumon H, Fuwamoto Y, Kondo S, Narumi T, Tanikawa T, Hirose M.

Traffic Inj Prev. 2019;20(sup1):S152-S156. doi: 10.1080/15389588.2019.1610170.

PMID:
31381449
2.

Spatial and seasonal variations in the biofunctional lipid substances (fucoxanthin and fucosterol) of the laboratory-grown edible Japanese seaweed (Sargassum horneri Turner) cultured in the open sea.

Terasaki M, Kawagoe C, Ito A, Kumon H, Narayan B, Hosokawa M, Miyashita K.

Saudi J Biol Sci. 2017 Nov;24(7):1475-1482. doi: 10.1016/j.sjbs.2016.01.009. Epub 2016 Jan 11.

3.

Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.

Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K.

Cell. 2018 Jul 26;174(3):636-648.e18. doi: 10.1016/j.cell.2018.06.011. Epub 2018 Jul 12.

4.

Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.

Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, Takamoto H, Miyaji Y, Nasu Y, Tsushima T, Kumon H.

World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31.

PMID:
29387931
5.

Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.

Sadahira T, Wada K, Araki M, Ishii A, Watanabe T, Nasu Y, Tsugawa M, Takenaka T, Nasu Y, Kumon H.

Int J Urol. 2017 Dec;24(12):842-847. doi: 10.1111/iju.13447. Epub 2017 Sep 20.

6.

Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.

Putranto EW, Kinoshita R, Watanabe M, Sadahira T, Murata H, Yamamoto KI, Futami J, Kataoka K, Inoue Y, Winarsa Ruma IM, Sumardika IW, Youyi C, Kubo M, Sakaguchi Y, Saito K, Nasu Y, Kumon H, Huh NH, Sakaguchi M.

Oncol Lett. 2017 Jul;14(1):1041-1048. doi: 10.3892/ol.2017.6201. Epub 2017 May 17.

7.

Robust cancer-specific gene expression by a novel cassette with hTERT and CMV promoter elements.

Sakaguchi M, Sadahira T, Ueki H, Kinoshita R, Murata H, Yamamoto KI, Futami J, Nasu Y, Ochiai K, Kumon H, Huh NH, Watanabe M.

Oncol Rep. 2017 Aug;38(2):1108-1114. doi: 10.3892/or.2017.5710. Epub 2017 Jun 12.

PMID:
28627633
8.

Effects of an autoinducer analogue on antibiotic tolerance in Pseudomonas aeruginosa.

Amoh T, Murakami K, Kariyama R, Hori K, Viducic D, Hirota K, Igarashi J, Suga H, Parsek MR, Kumon H, Miyake Y.

J Antimicrob Chemother. 2017 Aug 1;72(8):2230-2240. doi: 10.1093/jac/dkx132.

9.

Role of psl Genes in Antibiotic Tolerance of Adherent Pseudomonas aeruginosa.

Murakami K, Ono T, Viducic D, Somiya Y, Kariyama R, Hori K, Amoh T, Hirota K, Kumon H, Parsek MR, Miyake Y.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02587-16. doi: 10.1128/AAC.02587-16. Print 2017 Jul.

10.

A Pseudomonas aeruginosa Quorum-Sensing autoinducer analog enhances the activity of antibiotics against resistant strains.

Amoh T, Murakami K, Kariyama R, Hori K, Irie Y, Viducic D, Hirota K, Igarashi J, Suga H, Kumon H, Miyake Y.

J Med Invest. 2017;64(1.2):101-109. doi: 10.2152/jmi.64.101.

11.

Development of Endoscopic Diagnosis and Treatment for Chronic Unilateral Hematuria: 35 Years Experience.

Tanimoto R, Kumon H, Bagley DH.

J Endourol. 2017 Apr;31(S1):S76-S80. doi: 10.1089/end.2016.0747. Review.

PMID:
28322594
12.

Interfractional Seminal Vesicle Motion Relative to the Prostate Gland for Image-guided Radiotherapy for Prostate Cancer with/without Androgen Deprivation Therapy: A Retrospective Cohort Study.

Waki T, Katsui K, Mitsuhashi T, Ogata T, Katayama N, Takemoto M, Nasu Y, Kumon H, Kanazawa S.

Acta Med Okayama. 2017 Feb;71(1):31-39. doi: 10.18926/AMO/54823.

13.

Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.

Sawahara H, Shiraha H, Uchida D, Kato H, Kato R, Oyama A, Nagahara T, Iwamuro M, Horiguchi S, Tsutsumi K, Mandai M, Mimura T, Wada N, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Yagi T, Nasu Y, Kumon H, Okada H.

J Gastroenterol Hepatol. 2017 Oct;32(10):1769-1777. doi: 10.1111/jgh.13757.

PMID:
28168749
14.

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.

Suzawa K, Shien K, Peng H, Sakaguchi M, Watanabe M, Hashida S, Maki Y, Yamamoto H, Tomida S, Soh J, Asano H, Tsukuda K, Nasu Y, Kumon H, Miyoshi S, Toyooka S.

Anticancer Res. 2017 Jan;37(1):301-307.

PMID:
28011506
15.

In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging.

Sasaki T, Kobayashi K, Kita S, Kojima K, Hirano H, Shen L, Takenaka F, Kumon H, Matsuura E.

Autoimmun Rev. 2017 Feb;16(2):159-167. doi: 10.1016/j.autrev.2016.12.007. Epub 2016 Dec 15. Review.

PMID:
27988435
16.

Expression analysis of Dickkopf-related protein 3 (Dkk3) suggests its pleiotropic roles for a secretory glycoprotein in adult mouse.

Inoue J, Fujita H, Bando T, Kondo Y, Kumon H, Ohuchi H.

J Mol Histol. 2017 Feb;48(1):29-39. doi: 10.1007/s10735-016-9703-2. Epub 2016 Nov 19.

17.

Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.

Kumon H, Ariyoshi Y, Sasaki K, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Cancer Gene Ther. 2016 Nov;23(11):400-409. doi: 10.1038/cgt.2016.53. Epub 2016 Oct 21.

18.

Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.

Sadahira T, Wada K, Araki M, Ishii A, Takamoto A, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y, Kumon H; Okayama Urological Research Group (OURG).

J Antimicrob Chemother. 2017 Feb;72(2):529-534. doi: 10.1093/jac/dkw424. Epub 2016 Oct 12.

19.

Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer.

Hirata T, Park SC, Muldong MT, Wu CN, Yamaguchi T, Strasner A, Raheem O, Kumon H, Sah RL, Cacalano NA, Jamieson CHM, Kane CJ, Masuda K, Kulidjian AA, Jamieson CAM.

Asian J Urol. 2016 Oct;3(4):229-239. doi: 10.1016/j.ajur.2016.09.001. Epub 2016 Sep 12.

20.

A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.

Oka T, Kurozumi K, Shimazu Y, Ichikawa T, Ishida J, Otani Y, Shimizu T, Tomita Y, Sakaguchi M, Watanabe M, Nasu Y, Kumon H, Date I.

Sci Rep. 2016 Sep 14;6:33319. doi: 10.1038/srep33319.

21.

Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.

Sawahara H, Shiraha H, Uchida D, Kato H, Nagahara T, Iwamuro M, Kataoka J, Horiguchi S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Nasu Y, Kumon H, Okada H.

Cancer Gene Ther. 2016 Aug;23(8):278-83. doi: 10.1038/cgt.2016.31. Epub 2016 Jul 29.

22.

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.

Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M.

J Infect Chemother. 2016 Sep;22(9):581-6. doi: 10.1016/j.jiac.2016.06.010. Epub 2016 Jul 21.

PMID:
27452428
23.

Feasibility and effectiveness of a cosmetic intervention program for institutionalized older women in Japan.

Hayakawa Y, Shoji I, Kumon H, Tokita M, Kamata M, Arao T.

Prev Med Rep. 2016 Jun 16;4:242-7. doi: 10.1016/j.pmedr.2016.06.009. eCollection 2016 Dec.

24.

Clinical analysis of bacterial strain profiles isolated from urinary tract infections: A 30-year study.

Wada K, Uehara S, Yamamoto M, Sadahira T, Mitsuhata R, Araki M, Kobayashi Y, Ishii A, Kariyama R, Watanabe T, Nasu Y, Kumon H.

J Infect Chemother. 2016 Jul;22(7):478-82. doi: 10.1016/j.jiac.2016.04.004. Epub 2016 May 20.

PMID:
27217185
25.

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.

Xu P, Xu N, Guo K, Xu A, Takenaka F, Matsuura E, Liu C, Kumon H, Huang P.

Oncotarget. 2016 May 31;7(22):33025-34. doi: 10.18632/oncotarget.8846.

26.

The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.

Ariyoshi Y, Watanabe M, Eikawa S, Yamazaki C, Sadahira T, Hirata T, Araki M, Ebara S, Nasu Y, Udono H, Kumon H.

Gene Ther. 2016 May;23(5):408-14. doi: 10.1038/gt.2016.7. Epub 2016 Feb 2.

PMID:
26836118
27.

Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.

Ochiai K, Morimatsu M, Kato Y, Ishiguro-Oonuma T, Udagawa C, Rungsuriyawiboon O, Azakami D, Michishita M, Ariyoshi Y, Ueki H, Nasu Y, Kumon H, Watanabe M, Omi T.

Oncotarget. 2016 Jan 19;7(3):3283-96. doi: 10.18632/oncotarget.6488.

28.

Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.

Zhang Y, Li P, Xu A, Chen J, Ma C, Sakai A, Xie L, Wang L, Na Y, Kaku H, Xu P, Jin Z, Li X, Guo K, Shen H, Zheng S, Kumon H, Liu C, Huang P.

Tumour Biol. 2016 May;37(5):6653-9. doi: 10.1007/s13277-015-4298-x. Epub 2015 Dec 8.

PMID:
26646562
29.

Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mononuclear cells.

Uchida D, Shiraha H, Kato H, Sawahara H, Nagahara T, Iwamuro M, Kataoka J, Horiguchi S, Watanabe M, Takaki A, Nouso K, Nasu Y, Kumon H, Yamamoto K.

J Gastroenterol Hepatol. 2016 Jun;31(6):1154-9. doi: 10.1111/jgh.13259.

PMID:
26643412
30.

Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Araki M, Ebara S, Yanai H, Watanabe M, Nasu Y.

Clin Transl Sci. 2015 Dec;8(6):837-40. doi: 10.1111/cts.12362. Epub 2015 Dec 1.

31.

Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.

Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.

J Infect Chemother. 2015 Sep;21(9):623-33. doi: 10.1016/j.jiac.2015.05.014. Epub 2015 Jun 9.

PMID:
26166322
32.

A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.

Guo K, Huang P, Xu N, Xu P, Kaku H, Zheng S, Xu A, Matsuura E, Liu C, Kumon H.

Oncotarget. 2015 Aug 28;6(25):21137-47.

33.

A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.

Kobayashi K, Sasaki T, Takenaka F, Yakushiji H, Fujii Y, Kishi Y, Kita S, Shen L, Kumon H, Matsuura E.

J Immunol Res. 2015;2015:268172. doi: 10.1155/2015/268172. Epub 2015 Mar 25.

34.

Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy.

Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Ebara S, Hiraki T, Kanazawa S, Yanai H, Watanabe M, Nasu Y.

Clin Med Insights Oncol. 2015 Mar 23;9:31-8. doi: 10.4137/CMO.S23252. eCollection 2015.

35.

The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.

Kinoshita R, Watanabe M, Huang P, Li SA, Sakaguchi M, Kumon H, Futami J.

Oncol Rep. 2015 Jun;33(6):2908-14. doi: 10.3892/or.2015.3885. Epub 2015 Mar 30.

PMID:
25823913
36.

The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.

Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Hayami H, Takahashi S, Matsumoto T, Yamamoto S, Minamitani S, Watanabe A, Iwata S, Kaku M, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Kuroiwa K, Hirayama H, Narita H, Hosobe T, Ito S, Ito K, Kawai S, Ito M, Chokyu H, Matsumura M, Yoshioka M, Uno S, Monden K, Takayama K, Kaji S, Kawahara M, Sumii T, Kadena H, Yamaguchi T, Maeda S, Nishi S, Nishimura H, Shirane T, Yoh M, Akiyama K, Imai T, Kano M.

J Infect Chemother. 2015 May;21(5):340-5. doi: 10.1016/j.jiac.2015.01.010. Epub 2015 Jan 31.

PMID:
25727286
37.

A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment.

Fujio K, Watanabe M, Ueki H, Li SA, Kinoshita R, Ochiai K, Futami J, Watanabe T, Nasu Y, Kumon H.

Oncol Rep. 2015 Apr;33(4):1585-92. doi: 10.3892/or.2015.3770. Epub 2015 Jan 29.

38.

Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.

Shimazu Y, Kurozumi K, Ichikawa T, Fujii K, Onishi M, Ishida J, Oka T, Watanabe M, Nasu Y, Kumon H, Date I.

Gene Ther. 2015 Feb;22(2):146-54. doi: 10.1038/gt.2014.100. Epub 2014 Nov 13.

PMID:
25394252
39.

Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

Matsuda K, Takahashi A, Middlebrooks CD, Obara W, Nasu Y, Inoue K, Tamura K, Yamasaki I, Naya Y, Tanikawa C, Cui R, Figueroa JD, Silverman DT, Rothman N, Namiki M, Tomita Y, Nishiyama H, Kohri K, Deguchi T, Nakagawa M, Yokoyama M, Miki T, Kumon H, Fujioka T, Prokunina-Olsson L, Kubo M, Nakamura Y, Shuin T.

Hum Mol Genet. 2015 Feb 15;24(4):1177-84. doi: 10.1093/hmg/ddu512. Epub 2014 Oct 3.

40.

Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer.

Ma C, Liu C, Huang P, Kaku H, Chen J, Guo K, Ueki H, Sakai A, Nasu Y, Kumon H, Shimizu K, Watanabe M.

Oncol Lett. 2014 Aug;8(2):789-794. Epub 2014 May 26.

41.

[The Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index].

Takahashi S, Wada K, Kumon H, Masuda H, Suzuki Y, Yokoyama O, Homma Y, Takeda M.

Nihon Hinyokika Gakkai Zasshi. 2014 Apr;105(2):62-5. Japanese.

PMID:
24908819
42.

Molecular epidemiology and clinical implications of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from urine.

Sako S, Kariyama R, Mitsuhata R, Yamamoto M, Wada K, Ishii A, Uehara S, Kokeguchi S, Kusano N, Kumon H.

Acta Med Okayama. 2014;68(2):89-99.

44.

Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.

Togo Y, Kubo T, Taoka R, Hiyama Y, Uehara T, Hashimoto J, Kurimura Y, Takahashi S, Tsukamoto T, Miyazaki J, Nishiyama H, Kira S, Kiyota H, Yazawa S, Niwa N, Hongo H, Oya M, Kato T, Yasuda M, Deguchi T, Ishikawa K, Hoshinaga K, Matsumoto M, Shigemura K, Tanaka K, Arakawa S, Fujisawa M, Wada K, Uehara S, Watanabe T, Kumon H, Kobayashi K, Matsubara A, Matsumoto M, Sho T, Hamasuna R, Matsumoto T, Hayami H, Nakagawa M, Yamamoto S.

J Infect Chemother. 2014 Apr;20(4):232-7. doi: 10.1016/j.jiac.2013.10.003. Epub 2013 Dec 11. Erratum in: J Infect Chemother. 2014 Oct;20(10):660.

PMID:
24594451
45.

A rare complication: misdirection of an indwelling urethral catheter into the ureter.

Ishikawa T, Araki M, Hirata T, Watanabe M, Ebara S, Watanabe T, Nasu Y, Kumon H.

Acta Med Okayama. 2014;68(1):47-51.

46.

Robot-assisted radical prostatectomy: modified ultradissection reduces pT2 positive surgical margins on the bladder neck.

Araki M, Jeong W, Park SY, Lee YH, Nasu Y, Kumon H, Hong SJ, Rha KH.

Acta Med Okayama. 2014;68(1):35-41.

47.

Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review).

Watanabe M, Nasu Y, Kumon H.

Oncol Lett. 2014 Mar;7(3):595-601. Epub 2013 Dec 27.

48.

Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene.

Sakaguchi M, Watanabe M, Kinoshita R, Kaku H, Ueki H, Futami J, Murata H, Inoue Y, Li SA, Huang P, Putranto EW, Ruma IM, Nasu Y, Kumon H, Huh NH.

Mol Biotechnol. 2014 Jul;56(7):621-30. doi: 10.1007/s12033-014-9738-0.

49.

Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.

Shien K, Tanaka N, Watanabe M, Soh J, Sakaguchi M, Matsuo K, Yamamoto H, Furukawa M, Asano H, Tsukuda K, Nasu Y, Huh NH, Miyoshi S, Kumon H, Toyooka S.

PLoS One. 2014 Feb 3;9(2):e87900. doi: 10.1371/journal.pone.0087900. eCollection 2014.

50.

A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.

Watanabe M, Sakaguchi M, Kinoshita R, Kaku H, Ariyoshi Y, Ueki H, Tanimoto R, Ebara S, Ochiai K, Futami J, Li SA, Huang P, Nasu Y, Huh NH, Kumon H.

Oncol Rep. 2014 Mar;31(3):1089-95. doi: 10.3892/or.2013.2958. Epub 2013 Dec 31.

Supplemental Content

Support Center